Mycophenolic Acid/Betamethasone Sodium Phosphate

N/A

Report date: 2025/12/24 20:00:51

Base Information

Drug NameMycophenolic Acid/Betamethasone Sodium Phosphate
Drug Alias NameSURF-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInosine-5'-monophosphate dehydrogenase (IMPDH) inhibitorsGlucocorticoid receptor agonists
TargetsInosine-5'-monophosphate dehydrogenase (IMPDH)Glucocorticoid receptor
Therapy Area/IndicationsDry Eye Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Mycophenolic AcidBetamethasone Sodium Phosphate
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSurface Ophthalmics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSurface Ophthalmics Inc
Inactive CompaniesN/A
Active IndicationsDry Eye Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A